Chronic kidney disease-mineral and bone disorder (CKD-MBD) is one of the serious complications of long-term dialysis patients, which not only affects the life quality of dialysis patients, but also increases the death risk of dialysis patients. The existing research supports that the hyperphosphatemia is the initiating factor of CKD-MBD. Effective control of serum phosphorus level can improve patients' life quality and their prognosis. Sevelamer carbonate is a new type of phosphate binder, which has the exact effect and less side effects compared with the calcium-based phosphate binders. It has been proved to have other more benefits than reducing phosphorus. This paper reviews the clinical application of sevelamer carbonate in the treatment of CKD-MBD.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |